CONVALESCENT PLASMA FOR COVID-19 INFECTION: EVIDENCE AND CLINICAL APPLICATION
Corona virus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV2) and has currently affected 11 million people worldwide with 0.53 million deaths. While there is ongoing trials and research for newer therapeutic options including antivirals (remdesivir),...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Army Medical College Rawalpindi
2020-08-01
|
| سلاسل: | Pakistan Armed Forces Medical Journal |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://pafmj.org/PAFMJ/article/view/4943 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|